HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haoyue Qin Selected Research

Therapeutics

10/2023Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer.
7/2023Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics.
5/2023Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haoyue Qin Research Topics

Disease

3Neoplasms (Cancer)
03/2024 - 05/2023
2Lung Neoplasms (Lung Cancer)
10/2023 - 05/2023
1Microsatellite Instability
03/2024
1Hepatitis
10/2023
1Large Cell Carcinoma
05/2023
1Carcinoma (Carcinomatosis)
05/2023
1Neoplasm Metastasis (Metastasis)
01/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023
1Adenocarcinoma of Lung
01/2023
1Wounds and Injuries (Trauma)
01/2021

Drug/Important Bio-Agent (IBA)

3Immune Checkpoint InhibitorsIBA
10/2023 - 01/2023
2pembrolizumabIBA
03/2024 - 05/2023
1CytokinesIBA
10/2023
1adagrasibIBA
07/2023
1sotorasibIBA
07/2023
1Proteins (Proteins, Gene)FDA Link
07/2023

Therapy/Procedure

3Drug Therapy (Chemotherapy)
03/2024 - 01/2023
3Therapeutics
10/2023 - 05/2023
1Immunotherapy
07/2023
1Surgical Amputation (Amputations)
01/2021